TSX open
Loading markets…

Advertisement

Stocks

Why MedMira Inc stock is plummeting today

By Wealth Awesome -

This move is archived. Current quotes and coverage live on the stock page.

Stocks & ETFs:MIR.V

Follow MIR

Photos provided by Pexels

MedMira Inc's stock has taken a significant hit in today's trading session, raising concerns among investors.

In today's trading session, MedMira Inc (MIR.V) has seen its stock price drop by 14.29%, closing at CA$0.06. This decline has left many investors questioning the company's current trajectory and future prospects.

Advertisement

MedMira Inc

MIR.V

Full stock page →

MIR.V

MedMira Inc

Source:WealthAwesomeWealthAwesome
↑ $0.01 (7.69%)
120 day period
$0.06$0.07$0.07Mar 3Jun 16Sep 28

Market cap

$49.12M

52W high

$0.11

52W low

$0.05

1W change

+7.69%

Beta

0.80

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on MIR's historical volatility

HistoricalForecast68%95%
C$0.02C$0.07C$0.12C$0.17C$0.22C$0.27TodayApr 23Jul 9Sep 28Nov 10Dec 24Feb 5

30-Day Vol

100.1%

Annualized

90-Day Vol

98.3%

Annualized

Trend (90d)

+31.1%

Annualized drift

90d Mean

C$0.08

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.07C$0.05 – C$0.10
60 trading daysC$0.08C$0.05 – C$0.12
90 trading daysC$0.08C$0.04 – C$0.14

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should closely monitor MedMira's performance and any upcoming news that could impact its stock price, especially given the recent downturn.

14.29% Decline

MedMira's stock price fell sharply today, marking a notable downturn in its market performance amidst a challenging environment.

Bull case

Despite the current drop, MedMira has made progress in securing regulatory approvals for its diagnostic products. These approvals could pave the way for future revenue growth, offering some hope for investors.

Bear case

The significant decline in stock price today reflects ongoing concerns about MedMira's financial health and competitiveness in the market.

Market Reaction

Advertisement

The 14.29% drop in MedMira's stock price today mirrors a broader market sentiment that may be questioning the company's recent performance and future potential. Investors are likely reacting to the absence of significant news that could justify a recovery.

Financial Performance

MedMira recently reported a revenue of CA$241,000 for the third quarter, a figure that may not inspire confidence among investors. With no new developments announced today, the stock's decline might indicate a lack of faith in the company's growth strategy.

Looking Ahead

As MedMira navigates this downturn, investors should keep an eye on any forthcoming announcements regarding regulatory approvals or product launches. These factors could play a crucial role in determining the stock's trajectory in the coming weeks. For more details on MedMira's performance, check out our stock page.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: July 22, 2026
Last Updated: July 22, 2026

Core portfolio

Awesome Portfolio™

15.1% a year since 2017, against 9.9% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+15.1%

Awesome Portfolio™

+9.9%

S&P/TSX

+5.2 pp better a year

Total return

+260%

Awesome Portfolio™

+137%

S&P/TSX

+123 pp better than the TSX

2017-07-31 to 2026-09-17, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-17
-11.7%42.8%97.2%151.6%206.0%260.4%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement